RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
about
RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
RiMINI - the influence of rifa ...... a randomized controlled trial.
@en
type
label
RiMINI - the influence of rifa ...... a randomized controlled trial.
@en
prefLabel
RiMINI - the influence of rifa ...... a randomized controlled trial.
@en
P2093
P2860
P1433
P1476
RiMINI - the influence of rifa ...... a randomized controlled trial.
@en
P2093
Antonia Riegger
Christian Schulz
Friedhelm C Schmitt
Kerstin Schütte
Leon M Kliegis
Riccardo Vasapolli
Siegfried Kropf
P2860
P2888
P356
10.1186/S13063-016-1205-8
P577
2016-02-29T00:00:00Z
P5875
P6179
1009505342